We can't find the internet
Attempting to reconnect
12985.1;6 PFLS-LS
Design, optimization and validation of compounds against cancer-Initiating cells.
Zusammenfassung
Design, optimization and validation of compounds against cancer-Initiating cells.
Weitere Texte
Abstract
This CTI project aims at identifying a preclinical candidate and generate a selection of back-up compounds to treat brain cancer, in order to accelerate and improve the development programs of Stemergie Biotechnology SA. The combination of the unique technology expertise of Stemergie in cancer-initiating cells with the medicinal chemistry technologies and know-how of the Carreira Group at the ETH Zurich shall enable the development of novel drug candidates to treat brain cancer patients.
Beteiligte
Erick M. Carreira
Kontaktperson
carreira@org.chem.ethz.ch
ETHZ D-CHAB Erick M. Carreira Wolfgang-Paulistr. 10 8093 Zürich ZH CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2011-11-14
- Enddatum
- 2014-05-01
- Bewilligte Gesamtkosten
- CHF 614000.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Nicht aufteilbare / nicht zuteilbare Forschung
Forschungsdisziplinen
- T490 Biotechnology 100.0%